Table 3.
Medications and laboratory values for each patient at the time of hemoptysis
Patient | Episode | ERA | PDE-5 I | Digoxin | Warfarin | Platelets (microliter) | INR (unit) | BUN (mg/ dL) | Creatinine (mg/dL) |
---|---|---|---|---|---|---|---|---|---|
A | 1 | No | No | Yes | No | 72 | 1 | 16 | 1.3 |
2 | No | No | Yes | No | 63 | 1.1 | 17 | 1.4 | |
3 | No | No | Yes | No | 61 | 1.1 | 14 | 1 | |
4 | No | Sildenafil | Yes | No | 107 | 1.1 | 15 | 1.2 | |
5 | No | Sildenafil | Yes | No | 90 | 1 | 17 | 1.1 | |
6 | No | Sildenafil | Yes | No | 106 | 1 | 16 | 1.2 | |
7 | No | Sildenafil | Yes | No | 151 | 1.1 | 15 | 0.8 | |
8 | No | Sildenafil | Yes | No | 129 | 1.1 | 13 | 1.1 | |
9 | No | Sildenafil | Yes | No | 118 | 1.1 | 17 | 0.9 | |
B | 1 | No | No | Yes | No | 172 | 0.9 | 22 | 1 |
C | 1 | No | No | Yes | No | 165 | 1.1 | 15 | 1 |
D | 1 | No | No | Yes | No | 161 | 1.3 | 11 | 1 |
2 | No | No | Yes | No | 214 | 1.3 | 10 | 0.9 |
ERA, endothelin receptor antagonist; PDE5-I, phosphodiesterase 5-inhibitor.